Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2152 POSTS 0 COMMENTS

https://psynews.com

PT247 – Julian Vayne – Magic, Prohibition, and New Models for...

Psychedelic Bulletin: Poll Shows Support for Psilocybin in the UK; Psychedelics-tinged...

Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments

PTSF62 – Senate Bill 519, Ketamine, and Psilocybin-producing Cicadas

Op-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance

Mindset Selects its Lead Clinical Candidate, MSP-1014, a Next Generation Psychedelic...

Field Trip Health Ltd. to Commence Trading on the Toronto Stock...

MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use...

COMPASS Pathways and Kings College London publish cognition results from COMP360...

Psychedelics: A New Fountain of Youth?

1...210211212...216 Page 211 of 216

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin